1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits to the stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. PATIENT REGISTRY SOFTWARE MARKET BY REGISTRY TYPE
5.1. Introduction
5.2. Disease Registry
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.2.3. Cardiovascular Registry
5.2.4. Diabetes Registry
5.2.5. Cancer Registry
5.2.6. Rare Disease Registry
5.2.7. Others
5.3. Health Service Registry
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.4. Product Registry
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.4.3. Medical Device Registry
5.4.4. Drug Registry
6. PATIENT REGISTRY SOFTWARE MARKET BY SOFTWARE TYPE
6.1. Introduction
6.2. Stand-alone Software
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Integrated Software
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
7. PATIENT REGISTRY SOFTWARE MARKET BY FUNCTIONALITY
7.1. Introduction
7.2. Population Health Management
7.2.1. Market Trends and Opportunities
7.2.2. Growth Prospects
7.3. Health Information Exchange
7.3.1. Market Trends and Opportunities
7.3.2. Growth Prospects
7.4. Patient Care Management
7.4.1. Market Trends and Opportunities
7.4.2. Growth Prospects
7.5. Medical Research and Clinical Studies
7.5.1. Market Trends and Opportunities
7.5.2. Growth Prospects
7.6. Others
7.6.1. Market Trends and Opportunities
7.6.2. Growth Prospects
8. PATIENT REGISTRY SOFTWARE MARKET BY END-USER
8.1. Introduction
8.2. Hospitals
8.2.1. Market Trends and Opportunities
8.2.2. Growth Prospects
8.3. Government Organizations and Third-Party Administrators (TPAs)
8.3.1. Market Trends and Opportunities
8.3.2. Growth Prospects
8.4. Pharmaceutical, Biotechnology, and Medical Device Companies
8.4.1. Market Trends and Opportunities
8.4.2. Growth Prospects
8.5. Other
8.5.1. Market Trends and Opportunities
8.5.2. Growth Prospects
9. PATIENT REGISTRY SOFTWARE MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Registry Type
9.2.2. By Software Type
9.2.3. By Functionality
9.2.4. By End-User
9.2.5. By Country
9.2.5.1. United States
9.2.5.1.1. Market Trends and Opportunities
9.2.5.1.2. Growth Prospects
9.2.5.2. Canada
9.2.5.2.1. Market Trends and Opportunities
9.2.5.2.2. Growth Prospects
9.2.5.3. Mexico
9.2.5.3.1. Market Trends and Opportunities
9.2.5.3.2. Growth Prospects
9.3. South America
9.3.1. By Registry Type
9.3.2. By Software Type
9.3.3. By Functionality
9.3.4. By End-User
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.1.1. Market Trends and Opportunities
9.3.5.1.2. Growth Prospects
9.3.5.2. Argentina
9.3.5.2.1. Market Trends and Opportunities
9.3.5.2.2. Growth Prospects
9.3.5.3. Others
9.3.5.3.1. Market Trends and Opportunities
9.3.5.3.2. Growth Prospects
9.4. Europe
9.4.1. By Registry Type
9.4.2. By Software Type
9.4.3. By Functionality
9.4.4. By End-User
9.4.5. By Country
9.4.5.1. United Kingdom
9.4.5.1.1. Market Trends and Opportunities
9.4.5.1.2. Growth Prospects
9.4.5.2. Germany
9.4.5.2.1. Market Trends and Opportunities
9.4.5.2.2. Growth Prospects
9.4.5.3. France
9.4.5.3.1. Market Trends and Opportunities
9.4.5.3.2. Growth Prospects
9.4.5.4. Italy
9.4.5.4.1. Market Trends and Opportunities
9.4.5.4.2. Growth Prospects
9.4.5.5. Spain
9.4.5.5.1. Market Trends and Opportunities
9.4.5.5.2. Growth Prospects
9.4.5.6. Others
9.4.5.6.1. Market Trends and Opportunities
9.4.5.6.2. Growth Prospects
9.5. Middle East and Africa
9.5.1. By Registry Type
9.5.2. By Software Type
9.5.3. By Functionality
9.5.4. By End-User
9.5.5. By Country
9.5.5.1. Saudi Arabia
9.5.5.1.1. Market Trends and Opportunities
9.5.5.1.2. Growth Prospects
9.5.5.2. UAE
9.5.5.2.1. Market Trends and Opportunities
9.5.5.2.2. Growth Prospects
9.5.5.3. Others
9.5.5.3.1. Market Trends and Opportunities
9.5.5.3.2. Growth Prospects
9.6. Asia Pacific
9.6.1. By Registry Type
9.6.2. By Software Type
9.6.3. By Functionality
9.6.4. By End-User
9.6.5. By Country
9.6.5.1. Japan
9.6.5.1.1. Market Trends and Opportunities
9.6.5.1.2. Growth Prospects
9.6.5.2. China
9.6.5.2.1. Market Trends and Opportunities
9.6.5.2.2. Growth Prospects
9.6.5.3. India
9.6.5.3.1. Market Trends and Opportunities
9.6.5.3.2. Growth Prospects
9.6.5.4. South Korea
9.6.5.4.1. Market Trends and Opportunities
9.6.5.4.2. Growth Prospects
9.6.5.5. Taiwan
9.6.5.5.1. Market Trends and Opportunities
9.6.5.5.2. Growth Prospects
9.6.5.6. Thailand
9.6.5.6.1. Market Trends and Opportunities
9.6.5.6.2. Growth Prospects
9.6.5.7. Indonesia
9.6.5.7.1. Market Trends and Opportunities
9.6.5.7.2. Growth Prospects
9.6.5.8. Others
9.6.5.8.1. Market Trends and Opportunities
9.6.5.8.2. Growth Prospects
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Dacima Software Inc.
11.2. FIGmd Inc.
11.3. Global Vision Technologies Inc.
11.4. Image Trend Inc.
11.5. IQVIA
11.6. Ordinal Data, Inc.
11.7. McKensson Corporation
11.8. Syneos Health
11.9. Cerner Corporation
11.10. IBM
11.11. ArborMetrix